Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-15T22:21:04.065Z.
Calculation as of: 2026-09-15T22:21:04.065Z.
Quote observation: 2026-09-15T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0977b8a31e6ea7f9592b10cee9ae04021a425b0e7b389d5bba0cdf5189cd0787
PEG RATIO
N/A
Stryker Corporation
Market Cap
$107.92B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Stryker Corporation (SYK) | $107.92B | N/A |
| McKesson Corporation (MCK)vs › | $105.32B | N/A |
| Sanofi (SNY)vs › | $101.81B | N/A |
| GSK plc (GSK)vs › | $100.20B | N/A |
| Medtronic plc (MDT)vs › | $120.00B | N/A |
| CVS Health Corp. (CVS)vs › | $120.56B | N/A |
| HCA Healthcare, Inc. (HCA)vs › | $91.76B | N/A |
| Elevance Health Inc. (ELV)vs › | $90.55B | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $130.18B | N/A |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.62B | N/A |
PEG Ratio
N/A
P/E Ratio
29.2
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute